Quantum Computing, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a QUBT research report →
Range $10 – $22
Price Chart
About the company
Quantum Computing, Inc. (QUBT) is a Virginia-based technology firm dedicated to developing advanced software solutions for quantum computing. A cornerstone of their offerings is Qatalyst, a quantum application accelerator designed to empower developers.
- CEO
- Yuping Huang
- IPO
- 2007
- Employees
- 75
- HQ
- Hoboken, NJ, US
AI snapshot
Six angles, distilled from the data.
The stock is still in a corrective regime after a powerful run, trading below its 200-day average and well under the 52-week high of 25.84. The setup remains volatile, with a beta of 3.792, while the 52-week low at 6.18 shows the tape can reset sharply before stabilizing.
Street sentiment leans constructive, with a Buy consensus and an average target of 17.33 versus an 8.52 close. Recent changes are mixed but still supportive: Lake Street reiterated Buy, Rosenblatt reiterated Buy with a 22 target, while Cantor Fitzgerald stayed Neutral and kept a 10 target.
The next print comes after a choppy but improving beat pattern, with 5 of the last 8 quarters topping estimates. Near-term expectations remain negative, with next-year EPS estimated at -0.225, so shareholders should watch whether revenue growth can keep outpacing losses and whether the company can extend its recent beat streak.
The signal is mixed to mildly negative: there was net selling, but most of the activity was award and vesting noise rather than discretionary trading. The only clear open-market sale was by the CFO and General Counsel, while several large A-Award grants to executives and directors dilute the read on true insider conviction.
Profitability remains weak, with a gross margin of -18.9% and a net margin of -1.5245. Growth is the offset, as revenue rose 90% year over year, but operating cash flow was still -30.294 million and free cash flow was -23.604 million, so the business is scaling without consistent earnings power yet.
QUBT sits in the speculative end of the quantum and photonics group, where execution matters more than current earnings. The valuation still looks rich against a cash-burning profile, even with a large net cash position of 1.115 billion supporting the story.
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.82B
- P/E
- -125.27
- Fwd P/E
- 15.59
- PEG
- 0.67
- P/S
- 185.25
- P/B
- 1.14
- EV/EBITDA
- -254.09
- Div Yield
- 0.00%
- Gross Margin
- -18.92%
- Op Margin
- -775.48%
- Net Margin
- -152.45%
- ROE
- -1.06%
- ROIC
- -4.69%
Latest fiscal year · YoY change
- Revenue
- $682.00K+82.8%
- Gross Profit
- $67.00K-40.2%
- Op Income
- $-51,077,000
- Net Income
- $-18,674,000+72.8%
- EPS
- $-0.11+84.9%
- OCF Growth
- -86.9%
- FCF Growth
- -66.2%
- 52W High
- $25.84
- 52W Low
- $6.18
- 50D MA
- $8.92
- 200D MA
- $9.79
- Beta
- 3.78
- RSI (14)
- 42
- Avg Volume
- 14.95M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Quantum Computing Inc. said Q2 reflected rapid growth in revenue and commercial activity, driven by acquisitions, new customer wins, and continued investment in photonic and quantum manufacturing.· August 10, 2026
- Q2 revenue was $5.6 million, up from $61 thousand a year ago and up from $3.7 million in Q1.
- Net loss narrowed to $11.8 million, or $0.05 per share, versus a $36.5 million loss, or $0.26 per share, last year.
- Cash, cash equivalents and investments were about $1.3 billion at June 30, with total assets around $1.6 billion.
- Management said backlog was about $42.5 million and described it as work to be performed over 12 to 18 months.
- The company highlighted three acquisitions, a new Dirac-3 installation, a $10 million-plus potential Neurawave program, and an increased push into government and commercial sales.
Revenue for Q2 2026 totaled $5.6 million, compared with $61 thousand in Q2 2025 and $3.7 million in Q1 2026. Operating expenses were $21.8 million versus $10.2 million a year ago, with about $7.3 million of acquisition-related transaction expenses. Net loss was $11.8 million, or $0.05 per share, versus a net loss of $36.5 million, or $0.26 per basic share, in the prior-year period. Interest and other income was $13 million versus $1.8 million last year, helped by a larger cash position. Total assets were about $1.6 billion, cash/cash equivalents/investments were about $1.3 billion, liabilities were $47.2 million, and backlog was about $42.5 million. For forward commentary, management did not give formal quarterly revenue guidance; it said the company expects the business mix to remain lumpy, that backlog could support operations into third quarter of next year if no new business came in, and that QCI still stands by prior views that Enhanced could contribute somewhere between about $7.07 million and $16 million, while the company’s overall model had previously pointed to $20 million to $25 million for this year.
Yuping Huang emphasized that QCI is trying to turn its quantum roadmap into a broader commercial platform built on nanophotonics, advanced packaging, and U.S.-based semiconductor manufacturing. He framed the company’s goal as making quantum systems smaller, more practical, and more accessible, while also monetizing photonic products and services today. His tone was upbeat and confident, especially around Dirac-3 progress, the Neurawave commercialization milestone, and the idea that the company is reaching an inflection point for larger-scale market adoption.
Christopher Bruce Roberts focused on the quarter’s financial expansion and balance sheet strength. He cited Q2 revenue of $5.6 million, operating expenses of $21.8 million, and a net loss of $11.8 million, noting that the year-over-year loss improvement was largely driven by a smaller noncash derivative liability mark-to-market loss of $1.7 million versus $28 million last year. He said cash, cash equivalents and investments were about $1.3 billion, down from about $1.5 billion at year-end after roughly $180 million of cash used for acquisitions including Luminar Semiconductor, NuCrypt, and Enhanced Semiconductor, and he said upgrading the Enhanced facility could require roughly $50 million to $100 million, with about $75 million as a working estimate, though not this year.
Analysts focused on Dirac-3 functionality, backlog durability, end-market mix, and the financial impact of the Enhanced acquisition. Management said Dirac-3 has made progress on adding more variables and hinted at news in the coming month, while also explaining that the system is aimed at NP-hard optimization problems using room-temperature photonics rather than a quantum annealer. On backlog, management said the $42.5 million figure is not likely to be burned down quickly because the contracts run 12 to 18 months; on customers, they said government contracting currently accounts for roughly 70% to 80% of the business, mainly as a subcontractor, though commercial interest is rising. They also said the company is expanding sales coverage by hiring a new chief revenue officer and adding sales talent.
The call showed real revenue traction, with Q2 revenue up sharply year over year and sequentially, plus a much larger backlog than in prior periods. Management pointed to multiple commercial and technical catalysts: a Dirac-3 installation, Neurawave commercial readiness, a framework agreement that could exceed $10 million, and a very large cash position that supports acquisitions and manufacturing investment.
The business is still lumpy, heavily dependent on government subcontracting, and management repeatedly avoided formal guidance. They also acknowledged that scaling the Enhanced facility could require significant additional capital, that some projects and Navy-related funding have slipped, and that the commercial mix may take time to shift away from government work.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 89.3%
- Shares Outstanding
- 224.54M
- Float Shares
- 200.41M
of shares held by institutions
322 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 17.73M | ▲ 1.59M |
| Vanguard Group Inc | 16.84M | ▲ 4.64M |
| Vanguard Capital Management LLC | 8.85M | ▲ 86.59K |
| Penserra Capital Management LLC | 6.98M | ▲ 3.63M |
| Geode Capital Management, LLC | 5.32M | ▲ 622.34K |
| State Street Corp | 4.92M | ▲ 404.50K |
| Morgan Stanley | 3.29M | ▲ 971.28K |
| Marex Group PLC | 2.30M | ▼ 2.19M |
| Mirae Asset Global Etfs Holdings Ltd. | 2.27M | ▲ 69.23K |
| Ubs Group AG | 2.05M | ▲ 729.51K |
| Bank Of New York Mellon Corp | 1.98M | ▲ 953.09K |
| Northern Trust Corp | 1.82M | ▲ 126.01K |
Held by 237 ETFs
Biggest fund positions in QUBT by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 17, 26 | Hunt Susan G. | other | 0 |
| May 28, 26 | Huang Yuping | other | 58,558 |
| May 28, 26 | Huang Yuping | other | 23,588 |
| May 28, 26 | Dianat Pouya | other | 9,979 |
| May 28, 26 | Dianat Pouya | other | 24,774 |
| May 28, 26 | Begliarbekov Milan | other | 9,979 |
| May 28, 26 | Begliarbekov Milan | other | 24,774 |
| Apr 13, 26 | Weimer Carl Scott | other | 22,123 |
| Apr 13, 26 | TURMELLE MICHAEL C | other | 22,123 |
| Apr 13, 26 | Shabani Javad | other | 22,123 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our QUBT coverage
Recent articles, reports, and earnings notes.

TF3 Revolution, Revealed: What Stock Is Marc Lichtenfeld Teasing in The Oxford Income Letter?
Marc Lichtenfeld and The Oxford Club's The Oxford Income Letter are pitching the "TF3 Revolution"; here's the company behind the $20 stock claim and what the filings support.

D-Wave Quantum IPO: The Bull and Bear Case for QBTS
D-Wave Quantum Inc. (NASDAQ: QBTS) is expected to list on 2026-07-27, but the price range has not been disclosed. The setup is a bull case built on rapid revenue growth and a large cash balance, versus a bear case centered on dilution, losses, and a still-early quantum market.

What to Watch as Pasqal’s SPAC Merger Heads to a Vote
Pasqal, the French neutral-atom quantum computing company, is going public via a SPAC merger with Bleichroeder Acquisition France Merger Sub 2 (BBCQ). The setup is attractive if you want exposure to a real commercial quantum platform, but shareholders should watch redemption risk, dilution, and whether the financing stack holds together.
Want a deeper read on QUBT?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
AMD's $1.3 Billion Portfolio Reveals Its Biggest Investments and Where AI Demand Lands Next
247wallst.com · Aug 18
Here's How QUBT Expands Customer Adoption Across Quantum Platforms
zacks.com · Aug 18
Should You Buy, Hold or Sell QUBT Stock Amid Semiconductor Boom?
zacks.com · Aug 17
The Quantum Race Is Heating Up—And 2 Small Players Stand Out
marketbeat.com · Aug 17
Here's How QUBT Retains Financial Flexibility Amid Strategic Expansion
zacks.com · Aug 14
2 Quantum Stocks With 75%+ Upside in August After Q2 Earnings
zacks.com · Aug 13
California State Teachers Retirement System Boosts Stake in Quantum Computing Inc. $QUBT
defenseworld.net · Aug 13
Amundi Purchases Shares of 73,429 Quantum Computing Inc. $QUBT
defenseworld.net · Aug 12
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
AI analysis · Last refreshed August 19, 2026 · Live quote · Not investment advice